HorsesSmallholder Supplies

Equest Pramox Oral Gel

£22.03(exc VAT)£26.44(inc VAT)

A pale yellow to orange/pink gel containing 19.5 mg/g moxidectin and 121.7 mg/g praziquantel as active ingredients and 220.0 mg/g benzyl alcohol and 0.80 mg/g butyl hydroxytoluene as preservatives/antioxidants. Moxidectin is a second-generation macrocyclic lactone of the milbemycin family. Praziquantel is a parasiticide widely used in many species for the specific control of tapeworm.

One 11.8 g syringe contains sufficient gel to treat a 575 kg horse at the recommended dose rate (0.4 mg moxidectin per kg bodyweight and 2.5 mg praziquantel per kg bodyweight). Weight should be accurately determined.

The recommended dosing interval for the control of small redworm is 13 weeks. For optimum control of bots, this product should be administered in the autumn, after the end of the fly season and before spring as the larvae may start to pupate and therefore are less sensitive to treatment.

Legal category: POM-VPS

Withdrawal period: 64 days.

NOAH Datasheet

For the most up to date information about this product please look up the Summary of Product Characteristics (SPC) on the VMD webpage Product Information Database.

  • Price: £22.03(exc VAT)
    POM-VPS
    1. This medicines is classified POM-VPS or NFA-VPS and requires a Registered Qualified Person (RQP) to prescribe and dispense the product. You must check the box below before you can add this item to your basket. This product can cause harm to your animal if the guidelines of the product are not followed. Please tick and fill in the following:
    2. You have read the Summary of Product Characteristics (SPC). You have read the warnings and contra-indications and are aware of any withdrawals periods. You will use the product in accordance with the manufacturers direction set out in the SPC. If you are still unsure you will contact our RQP.
    3. I wish to be contacted by a RQP to discuss this product further.
Equest Pramox Oral Gel
Like most sites this site uses cookies : By continuing to use our site you are agreeing to our cookie policy.close & accept